APA (7th ed.) Citation

Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., . . . Bluestone, J. A. (2005). A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes. Diabetes (New York, N.Y.), 54(6), 1763-1769. https://doi.org/10.2337/diabetes.54.6.1763

Chicago Style (17th ed.) Citation

Herold, Kevan C., et al. "A Single Course of Anti-CD3 Monoclonal Antibody HOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years After Onset of Type 1 Diabetes." Diabetes (New York, N.Y.) 54, no. 6 (2005): 1763-1769. https://doi.org/10.2337/diabetes.54.6.1763.

MLA (9th ed.) Citation

Herold, Kevan C., et al. "A Single Course of Anti-CD3 Monoclonal Antibody HOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years After Onset of Type 1 Diabetes." Diabetes (New York, N.Y.), vol. 54, no. 6, 2005, pp. 1763-1769, https://doi.org/10.2337/diabetes.54.6.1763.